uMotif - News

uMotif Announce New Technology Advisor - Dr Alison Vincent, Former Cisco Chief Technology Officer

Building an advisory board of world-leading experts to make patient-centric clinical research a reality

We Are Hiring!

Want to be part of a team building software that is speeding drug development as well as putting patients at the centre?

uMotif Welcome Rachel Lowrey as Head of Marketing

Expanding the team to support global growth

uMotif Sponsoring 2019 ACDM Annual Conference

We look forward to the discussions and busting BYOD myths

Focusing On Company Culture

Our ‘uWrite’ employee interview series continues with insight into how we maintain our uMotif identity and culture as the company grows.

uMotif recognised in the Global Digital Health 100 for second year running

uMotif highlighted again as one of the most innovative health technology companies by The Journal of mHealth

uMotif to attend SCOPE Summit 2019 in Orlando

uMotif team to join life science industry leaders for in-depth discussion and breakout sessions on the latest advances in all aspects of clinical trial management and operations

uMotif to attend DIA Europe 2019 Conference in Vienna

uMotif team to join life science industry leaders, payers, patients and regulators to drive collaborative answers in medicines development and access to healthcare

Read Applied Clinical Trials article: Me, We and RWE

Featuring uMotif CEO Bruce Hellman and long-time collaborators Helen Matthews, The Cure Parkinson’s Trust and Jessica Morris, OurBrainBank

Partnerships in Clinical Trials 2018: My top three takeaways

uMotif CEO, Bruce Hellman, shares his highlights from PCT 2018

Read our ‘Real-World Evidence Mythbusting’ article in Clinical Trials Innovation

Our CEO, Bruce Hellman, takes on the five most common myths holding back patient-reported adoption and busts them one by one.

Join our Webinar: Delivering Patient-Centric Late Phase Research Using the Latest BYOD ePRO

Register for our latest webinar, featuring expert discussion with Professor Will Dixon, Chair in Digital Epidemiology at University of Manchester, Willie Muehlhausen and uMotif CEO Bruce Hellman.

Read industry expert Dr Calum MacRae’s latest article in Clinical Leader

Featuring uMotif: Leading cardiologist and leader of One Brave Idea, Dr Calum MacRae, discusses the importance of capturing real-world evidence to close the gap between the R&D process and healthcare delivery.

uMotif attending Partnerships in Clinical Trials Europe Conference in Barcelona

uMotif team to join pharma, biotech and CRO experts to discuss the importance of patient engagement and the impact of real world evidence on clinical research

uMotif delighted to announce Willie Muehlhausen, eCOA subject matter expert, as member of advisory board

uMotif building an advisory group of world-leading experts to make patient-centric clinical research a reality

Read our latest article in Applied Clinical Trials

Check out our latest article exploring the importance of human centred design for true patient centricity in pharmaceutical research, authored by our CEO Bruce Hellman and IDEO Portfolio Director Betsy Fields Smith.

We're Hiring!

We're further strengthening our sales and marketing team - putting the patient at the centre of clinical research. Come and join us!

An Unforgettable First SCDM Experience in Seattle

uMotif CEO, Bruce Hellman, shares his highlights from SCDM 2018

uMotif attending SCDM 2018 Annual Conference in Seattle

uMotif team to join life science & data management colleagues to discuss the importance of patient-centric design in real world data capture

uMotif nominated for OBN award

We're a finalist in the 'Best implementation of digital technology for healthcare' category

Our employee interview series continues with a technology focus

Learn about how we manage our Infrastructure and ensure performance with Michal and Greg

uMotif secures £2.4 million funding - led by Albion Capital

We're delighted to secure this round of funding. It will enable us to bring on even more world class talent and remain at the forefront of patient-centric technology.

uMotif and OMRON Healthcare join forces to deliver patient-centred clinical research of the future

Creating a complete solution for cost-efficient, fast and high-quality clinical research by integrating high quality vitals, eCOA / ePRO and symptoms data

We're hiring!

We're growing across the company - building the team to put patients at the centre of clinical research. Come join us!

uMotif welcome Jonathan Stone as Vice President of Business Development (Americas and APAC)

uMotif investing in top business development talent to help the industry put the patient at the centre of clinical research.

Guardian Article: The app that could save lives by speeding up drug trials

uMotif profiled in major newspaper highlighting the importance of patient first trials and people owning their own data

Introducing our series of employee blogs and interviews with the uMotif team.

uWrite Volume 1: Quality with Michael Burke, QMS specialist

Knect 365 article: Enabling Bring Your Own Device Clinical Data Collection

uMotif CEO Bruce Hellman explores how patient-centric data capture can revolutionise clinical trials

uMotif collaborating with IQVIA and Emis Health for NIHR We've Got Your Back study

Unique approach to use an integrated platform to help GPs recruit more patients in clinical research

OurBrainBank publishes first feedback from patients

The glioblastoma initiative, supported by uMotif, is receiving fantastic feedback from patients and their caregivers as well as insights into what they expect from their care

Steve Powell joins uMotif Board of Directors

uMotif adds the accomplished software leader behind some of the most successful patient engagement and clinical trial management platforms to our leadership team.

uMotif featured in the Promise of HealthTech report

Report names uMotif as one of the 27 most promising HealthTech companies

uMotif partnering with Novartis and IQVIA on NHS Cancer Vanguard project

We’re delighted to be providing our data capture platform to support this work

5 Reasons to Join a Trade Mission

Rob Nichols, VP of Customer Experience, fresh from such a trip to Vienna, gives his view

Read our article published in the latest Journal of mHealth

Driving Real-World Research Through Patient-Centric Engagement

Our team grows with over 10 new hires since the start of 2018

We're building the team to deliver next generation patient data capture platform for clinical research

uMotif powered non-profit tackling brain cancer is now live

OurBrainBank is created by, with and for patients with Glioblastoma - one of the most aggressive, complex and deadly forms of cancer.

We’re recruiting!

We’re currently growing our engineering, sales and account delivery teams as we take our patient-centric approach to more clients and patients.

uMotif nominated by Journal of mHealth in the 'Global Digital Health 100'

We're delighted to have been nominated as one of the world's leading digital health companies by the Journal of mHealth

Deployment in colorectal cancer at Christie Cancer Vanguard proven successful

A poster presentation at the BOPA conference in the UK shows successful deployment of uMotif at the Christie hospital

uMotif platform proven to engage patients in studies

A paper published in JMIR demonstrates that uMotif is the most effective platform to engage patients in data capture for research

Patients, like holidaymakers, should be at the centre of their journey

Hotwire featured an article on patient centricity by our CEO, Bruce Hellman

Self-tracking proven to improve cancer survival rates

A peer-review published study has shown that patients who self-track their health have significantly better cancer outcomes and survival rates

uMotif powering new patient-centric movement in brain cancer

A new patient-powered movement - Our Brain Bank - aims to move brain cancer from terminal to treatable, powered by patients using uMotif technology

Amazon Web Services case study on uMotif

Our cloud based data capture technology has been featured as a case study by Amazon Web Services, our hosting provider

uMotif wins 'Professional's Choice' category at AXA PPP HealthTech & You Awards

We picked up another award at the AXA PPP HealthTech & You Awards, scooping the 'Professional's Choice' category for engaging patients in large-scale research projects

New partnership with SQN for patient-centric data capture for clinical trials

Our new partnership will provide clinical trial sponsors with patient-centric technology for trials of all phases, including Real-World Evidence.

uMotif featured on BBC World Service 'World Hacks' programme

The BBC World Service's programme 'World Hacks' covered the growing interest in patients donating their health data for research, focusing on the uMotif platform

The dataset from 100 For Parkinson's exceeds 2.2 million data points

The final patients have completed their 100 Days of tracking for 100 For Parkinson's, so we now have the final dataset containing over 2.2 million datapoints. The latest analyses are ...

uMotif signs new partnership with AstraZeneca to enhance patient data capture

uMotif has signed a partnership agreement with AstraZeneca, a top-10 global pharmaceutical company

uMotif and QuintilesIMS in partnership with the NHS Cancer Vanguard and Merck launch a unique investigation into the experience of Colorectal Cancer Patients

uMotif in partnership with QuintilesIMS was chosen from dozens of responses to the ‘Pharma Challenge’, an invitation issued by the NHS Cancer Vanguard to the pharmaceutical and life sciences industry to help the NHS make better use of medicines and minimise waste.

Gold-standard RCT shows that uMotif effectively engages patients to track and manage their condition over time - resulting in significant clinical impact

A new study in Parkinson’s proves the value and clinical impact of patients using their own devices to capture and monitor symptoms and treatments.

Capturing trial data to help understand the good days, as well as the bad: Sam's Story

Using the uMotif app during the Smart PD trial, Sam was able to get a better understanding of her Parkinson's

uMotif announce partnership with Global Kinetics

Global Kinetics Corporation and uMotif have announced a new partnership to offer a comprehensive, validated and simple to use data capture platform to advance the treatment and understanding of Parkinson's disease.

Putting patients at the centre of research - Mick's experience of using uMotif

Watch the latest video, where one of the participants from our observational study describes his experience using the uMotif app

Cloudy with a Chance of Pain is Front Page News!

Our collaboration with the University of Manchester is featured on the FRONT PAGE of the Daily Express today - describing the preliminary findings that the weather may.....

100 For Parkinson’s enters its last two weeks of recruitment

Our ground-breaking study in partnership with The Cure Parkinson’s Trust, Parkinson’s UK and the European Parkinson’s Disease Association is entering the last two weeks of recruitment. There’s still time for people with Parkinson’s and healthy volunteers to join over 4000 others and track their health for 100 days using their own smartphone or tablet.

Digital Innovators Power List

umotif has been named as one of the South East's most visionary digital companies in the inaugural 'Digital Innovators Power List' launched today by international law firm Bird & Bird LLP and London-based news brand, City A.M.

uMotif and Oxford University Innovation collaborate on world’s largest health tracking study to improve the lives of those with Parkinson’s

One person in every 500 has Parkinson’s disease, with more than 127,000 people in the UK and around 10 million people globally diagnosed with the condition. A unique global health project – 100 for Parkinson’s - has engaged thousands of people across the world to track their health, using smartphone technology, to provide valuable new insights on the impact of Parkinson’s on their daily lives. With over 4,000 participants and millions of data points captured, the study is now the world’s largest of its type in Parkinson’s, capturing more high quality health data from more patients over a longer period of time.

It's World Parkinson's Congress and we've more data to share...

World Parkinson's Congress is ending today in Portland, so we've published some more data from 100 For Parkinson's on Mood, Sleep and Stress levels of those with and without Parkinson's...

Cloudy with a Chance of Pain study

Preliminary results, national media coverage and another 2,500 participants: It's been another couple of eventful weeks for the ground-breaking Cloudy with a Chance of Pain study

Partnership with Picker Institute, using patient experience to reduce readmissions

We're delighted to be working in partnership with the Picker Institute – the leading charity improving healthcare through measurement of experience.

Data from global 100 for Parkinson’s study

We launched our global 100 for Parkinson's study at the start of 2016, and have had an incredible response.

Guardian article: People powered health

uMotif CEO Bruce Hellman wrote an article in the Guardian on the future of technology in healthcare.

IDEO Startup In Residence

A year ago the uMotif team started working with the IDEO London team, as part of their incredible Startup In Residence Programme.